Benign Migratory Glossitis in a Patient With Cholangiocarcinoma due to Targeted Drug Therapy
Clinical Case Reports · 2026-06 · 14 (6)
DOI: 10.1002/ccr3.72813 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 25.05.2026. Verfasst von Sandeep Gurav und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dental and Prosthetic Surgery, Tata Memorial Hospital A CI of Homi Bhabha National Institute Mumbai India. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
During the course of targeted drug therapy, a cancer patient may manifest a myriad of systemic and oral toxicities. This has a direct impact on the patient's QOL. This clinical image highlights a rarely‐encountered oral mucosal alteration called benign migratory glossitis in a case of cholangiocarcinoma who was subjected to bevacizumab.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dental and Prosthetic Surgery, Tata Memorial Hospital A CI of Homi Bhabha National Institute Mumbai India.
ORCID-Profile: Radhika Jain
Zitieren
APA
Gurav, S., Singh, G. P., & Jain, R. (2026). Benign Migratory Glossitis in a Patient With Cholangiocarcinoma due to Targeted Drug Therapy. Clinical Case Reports, 14(6). https://doi.org/10.1002/ccr3.72813
Vancouver
Gurav S, Singh GP, Jain R. Benign Migratory Glossitis in a Patient With Cholangiocarcinoma due to Targeted Drug Therapy. Clinical Case Reports. 2026;14(6). doi:10.1002/ccr3.72813
BibTeX
@article{Gurav2026,
author = {Gurav, Sandeep and Singh, Gurkaran Preet and Jain, Radhika},
title = {Benign Migratory Glossitis in a Patient With Cholangiocarcinoma due to Targeted Drug Therapy},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {6},
doi = {10.1002/ccr3.72813}
}
EUVIMED